UBS Initiates Coverage on Novo Nordisk (NVO) with a Neutral
UBS initiates coverage on Novo Nordisk (NYSE: NVO) with a Neutral.
Novo Nordisk A/S is a Denmark-based healthcare company. The Company provides diabetes care and has diabetes product portfolio in the industry, including insulin delivery systems.
Related Categories
New CoverageStocks Mentioned
Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
